Viewing Study NCT02004769


Ignite Creation Date: 2025-12-24 @ 11:13 PM
Ignite Modification Date: 2026-04-04 @ 6:01 AM
Study NCT ID: NCT02004769
Status: COMPLETED
Last Update Posted: 2016-11-18
First Post: 2013-09-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Trastuzumab Plus Docetaxel and Capecitabine For First Line Treatment of Her2-Positive Advanced Gastric Cancer
Sponsor: Sun Yat-sen University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module